Reverse Break-up Fees and Specific Performance: A Survey of Remedies in Leveraged Public Deals (2015 Edition) | Practical Law
A study analyzing the remedies available to target companies in public merger agreements for a buyer's failure to close the transaction because of a breach or financing failure. The study covers all merger agreements entered into in 2014 for debt-financed acquisitions of US reporting companies (excluding REITs and debt-only issuers) with an equity value at signing of at least $100 million.